Genscript Biotech (HKSE:01548) Price-to-Tangible-Book : 2.46 (As of May. 15, 2024)

View and export this data going back to 2015. Start your Free Trial

What is Genscript Biotech Price-to-Tangible-Book?

As of today (2024-05-15), Genscript Biotech's share price is HK$12.42. Genscript Biotech's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$5.05. Hence, Genscript Biotech's Price to Tangible Book Ratio of today is 2.46.

The historical rank and industry rank for Genscript Biotech's Price-to-Tangible-Book or its related term are showing as below:

HKSE:01548' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.84 Med: 5.59 Max: 20.73
Current: 2.46

During the past 10 years, Genscript Biotech's highest Price to Tangible Book Ratio was 20.73. The lowest was 1.84. And the median was 5.59.

HKSE:01548's Price-to-Tangible-Book is ranked better than
55.08% of 1220 companies
in the Biotechnology industry
Industry Median: 2.71 vs HKSE:01548: 2.46

A closely related ratio is called PB Ratio. As of today, Genscript Biotech's share price is HK$12.42. Genscript Biotech's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$5.12. Hence, Genscript Biotech's P/B Ratio of today is 2.42.

Genscript Biotech Price-to-Tangible-Book Historical Data

The historical data trend for Genscript Biotech's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genscript Biotech Price-to-Tangible-Book Chart

Genscript Biotech Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

13.39

2.72

9.22

6.85

3.93

Genscript Biotech Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial														9.22	10.66	6.85	3.58	3.93

Competitive Comparison of Genscript Biotech's Price-to-Tangible-Book

For the Biotechnology subindustry, Genscript Biotech's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Genscript Biotech's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Genscript Biotech's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Genscript Biotech's Price-to-Tangible-Book falls into.

Genscript Biotech Price-to-Tangible-Book Calculation

Genscript Biotech's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	12.42	/	5.049
	=	2.46

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Genscript Biotech Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Genscript Biotech's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Genscript Biotech (HKSE:01548) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Genscript Biotech Corp (HKSE:01548) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

GNNSF:USA G51:Germany

Address

No. 28, Yongxi Road, Jiangning Science Park, Jiangsu Province, Nanjing, CHN, 211100

Website

https://www.genscript.com

GenScript Biotech is a China-based provider of life science research services and products. Founded in 2002, it is best known for its gene synthesis capabilities, a widely used service by academics, biotech companies, and pharmaceutical companies around the world. Its business lines include life science research services and products, biologics development services under its ProBio brand, and industrial enzymes under its Bestzyme brand. Finally, it owns 57.1% of Nasdaq-listed Legend Biotech, whose key pipeline asset is a BCMA-targeting CAR-T treatment for multiple myeloma. We estimate that more than two thirds of GenScript's valuation is from its ownership stake in Legend.

Genscript Biotech (HKSE:01548) Headlines

No Headlines